Name | Androsta-1,4,6-triene-3,17-dione |
Synonyms | ATD Androsta-1 6-triene-3 Δ1,4,6-androgen 1,4,6-Andorstatriene-3,17-dione androsta-1,4,6-triene-3,17-dione Androsta-1,4,6-triene-3,17-dione 1,4,6-Androstatriene-3,17-dione(ATD) ANDROSTA-1,4,6-TRIENE-3,17-DIONE(ATD) |
CAS | 633-35-2 |
EINECS | 1806241-263-5 |
InChI | InChI=1/C19H22O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3-4,7,9,11,14-16H,5-6,8,10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1 |
Molecular Formula | C19H22O2 |
Molar Mass | 282.38 |
Density | 1.16±0.1 g/cm3(Predicted) |
Melting Point | 164-1650C |
Boling Point | 452.8±45.0 °C(Predicted) |
Flash Point | 168.7°C |
Solubility | methanol: 50mg/mL, soluble |
Vapor Presure | 2.17E-08mmHg at 25°C |
Appearance | powder |
Storage Condition | -20°C Freezer |
Refractive Index | 1.587 |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
RTECS | BV8082250 |
biological activity | Androsta-1,4,6-triene-3,17-dione is a lipophilic and specific aromatase inhibitor, the Ki value was 0.18 μm. Androsta-1,4,6-triene-3,17-dione can inhibit estrogen biosynthesis and has contraceptive effect. Androsta-1,4,6-triene-3,17-dione can induce spatial memory impairment. |
Target | Ki: 0.18 μm (aromatase) |
Animal Model: | Rats (220-250 g) |
Dosage: | 25 mg/kg, 100 mg/kg |
Administration: | Subcutaneous injection |
Result: | Prevented the normal rise in ovarian estradiol concentrations with a single injection 3 hours before the time of the estrogen surge on proestrus. |